Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma

specific

A mature T-cell and NK-cell non-Hodgkin lymphoma of intraepithelial T-lymphocytes. It usually arises from the small intestine. A minority of cases arise from the large intestine or the stomach. It is characterized by the presence of a monomorphic cellular infiltrate of small to medium-sized T-lymphocytes that are cytotoxic and express CD56. It is not associated with celiac disease.

Centers

Active Trials

$2M

Cancer Funding

Top Centers for Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma(37)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program	Active Research Program	1	—	66.7
2	Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program	Active Research Program	1	—	66.7
3	Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program	Active Research Program	1	—	66.7
4	University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program	Active Research Program	1	—	66.7
5	Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program	Active Research Program	1	—	66.7
6	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical Active Research Program	Active Research Program	1	—	66.7
7	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program	Active Research Program	1	—	66.7
8	University of Illinois Cancer CenterChicago, IL Active Research Program	Active Research Program	1	—	66.7
9	Boston University Cancer CenterBoston, MA Active Research Program	Active Research Program	1	—	66.7
10	Cancer Center at IllinoisUrbana, IL Active Research Program	Active Research Program	1	—	66.7
11	Tampa General Hospital Cancer InstituteTampa, FL Active Research Program	Active Research Program	1	—	66.7
12	Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program	Active Research Program	—	$2M	61.7
13	Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive		—	—	44.2
14	Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive		—	—	44.2
15	Siteman Cancer CenterSt. Louis, MO NCI Comprehensive		—	—	44.2
16	UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive		—	—	44.2
17	Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive		—	—	44.2
18	Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive		—	—	44.2
19	UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive		—	—	44.2
20	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive		—	—	44.2
21	Winship Cancer InstituteAtlanta, GA NCI Comprehensive		—	—	44.2
22	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive		—	—	44.2
23	University of Wisconsin Carbone Cancer CenterMadison, WI NCI Comprehensive		—	—	44.2
24	City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive		—	—	44.2
25	Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive		—	—	44.2
26	Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive		—	—	44.2
27	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive		—	—	44.2
28	Cedars-Sinai CancerLos Angeles, CA		—	—	44.2
29	Wilmot Cancer Institute, UR MedicineRochester, NY NCI Clinical		—	—	44.2
30	Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive		—	—	44.2
31	The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive		—	—	44.2
32	Dartmouth Cancer CenterLebanon, NH NCI Comprehensive		—	—	44.2
33	UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR		—	—	44.2
34	University of Cincinnati Cancer CenterCincinnati, OH		—	—	44.2
35	Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL		—	—	44.2
36	Georgia Cancer Center, Augusta UniversityAugusta, GA		—	—	44.2
37	The University of Vermont Cancer CenterBurlington, VT		—	—	44.2

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →